APA

Badings E. A., Dyal L., Schoterman L., Lok D. J. A., Stoel I., Gerding M. N., Gerstein H. C. & Tijssen J. G. P. (20120125). Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population. : Journal of diabetes.

Chicago

Badings Erik A, Dyal Lyanne, Schoterman Lydia, Lok Dirk J A, Stoel Ies, Gerding Martin N, Gerstein Hertzel C and Tijssen Jan G P. 20120125. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population. : Journal of diabetes.

Harvard

Badings E. A., Dyal L., Schoterman L., Lok D. J. A., Stoel I., Gerding M. N., Gerstein H. C. and Tijssen J. G. P. (20120125). Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population. : Journal of diabetes.

MLA

Badings Erik A, Dyal Lyanne, Schoterman Lydia, Lok Dirk J A, Stoel Ies, Gerding Martin N, Gerstein Hertzel C and Tijssen Jan G P. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population. : Journal of diabetes. 20120125.